Delivery Order SPE2DB24D2013-SPE2DB26FCGQQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,247.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 16, 2025, with completion scheduled for July 17, 2025. This competitive, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $41,898.36 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed-price contract. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $58,252.86 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed price contract. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,544.19 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded and is scheduled for completion by September 29, 2025. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a $42,420.50 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery to support military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,245.81 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,331.02 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure. This delivery order is executable through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,893.98 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 packs) on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a $40,900.74 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on September 16, 2025, with an ultimate completion date of September 17, 2025. The award was made on a competitive, non-set-aside basis under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,769.77 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB26FCGQQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,437.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 10/24/25 |